NovelBiome

NovelBiome is a Netherlands-based biotechnology company specializing in microbiome restoration through standardized fecal microbiota transplantation (FMT) therapies. The company operates a high-throughput processing and screening platform to produce safe, encapsulated, and liquid microbiota products for clinical research and therapeutic use. NovelBiome focuses primarily on the gut-brain axis, with lead clinical programs targeting Autism Spectrum Disorder (ASD) to improve both gastrointestinal and behavioral symptoms. In addition to its therapeutic pipeline, the company provides high-quality microbiome materials to academic and clinical partners for the treatment of Clostridioides difficile infections and other gut-related disorders.